Viewing nowCombinationZepazine Duo Tablets 12.5/850 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.

MFDS item code 202501819 · Approved 2025.07.17 · Insurance code 645406580
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to improve blood sugar control in adult patients with type 2 diabetes by complementing dietary and exercise therapy through the combination of empagliflozin and metformin. It is particularly effective for patients whose blood sugar is not well controlled, and may also be used with caution in patients with cardiovascular disease to prevent cardiovascular events. This medication helps enhance overall blood sugar management.
The recommended dose is 1 tablet twice daily. The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. For patients whose glycemic control is inadequate with metformin alone or in combination with other medicines, such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated but additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia. This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If a dose is missed, take it as soon as remembered. However, do not take a double dose at one time; in this case, skip the missed dose. No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min, provided they do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated using empagliflozin and metformin as separate single-ingredient products. The maximum daily dose of metformin hydrochloride that may be administered using this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months. If renal function declines to CrCl <45 ml/min or eGFR <45 ml/min/1.73m2, this medicine should be discontinued immediately. In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication is used for the treatment of diabetes and aids in blood sugar control. When taking this medication, kidney function should be regularly monitored to ensure it is normal, and it should not be used if kidney function is severely impaired. This medication should not be taken in cases of severe infections, dehydration, or acute heart disease. It is advisable that pregnant women or women of childbearing potential, and breastfeeding women, refrain from using this medication. This medication can cause hypoglycemia, so caution is necessary when taken alongside insulin or other hypoglycemic agents, and dose adjustments may be required. Rare but serious side effects such as lactic acidosis may occur; if symptoms such as malaise, muscle pain, difficulty breathing, or abdominal pain arise, immediate consultation with a physician is necessary. Moreover, this medication may increase the risk of urinary tract infections or genital infections, so rapid treatment is required if infection symptoms are present. When undergoing surgery or iodine contrast imaging tests, this medication should be temporarily discontinued and resumed only after ensuring normal kidney function post-testing. Alcohol consumption may increase the risk of lactic acidosis, so excessive drinking should be avoided while taking this medication. Elderly patients or those at risk of fluid loss should be vigilant about dehydration and hypotension, and regular blood tests and kidney function assessments are important. This medication is not recommended for children, and any unusual reactions should be reported to healthcare personnel immediately. Finally, this medication should be stored out of reach of children and kept in its original container to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. The recommended storage temperature is at room temperature between 1°C and 30°C.
Biconvex oval film-coated tablet with a pinkish white color
Bottle - 60 tablets/bottle, PTP - 60 tablets/box [(10 tablets/PTP x 6)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.